The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

Also called NCT02254655

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose supportive care
Phase
Phase 2
Enrolled
  • 119 participants (enrolled count) (from the registry)
Sponsor
Chengdu PLA General Hospital (from the registry)
Registry
  • NCT NCT02254655
Other papers using this trial's data
  • The Effect of Puerarin on Carotid Intima-media Thickness in Patients With Active Rheumatoid Arthritis: ARandomized Controlled Trial Clinical therapeutics, 2018-10 DOI, PubMed 30245282

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02254655. Randomized; single masking; primary purpose supportive care. Start 2013-11 (actual); primary completion 2017-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis
Condition
Rheumatoid Arthritis
Intervention (Drug)
Puerarin injection 400 mg
Intervention (Drug)
Control
Lead sponsor
Chengdu PLA General Hospital (class: other)

Record details

Record id
cardio:ct-nct02254655
Content hash
a8682bbfb16bc60f0028d06083fd624bde7adebb1dbc5e50a97690eb47a06e63